Sign in
4

Changes in Ownership

Rani Therapeutics Holdings, Inc. Filed Acc 0000950170-25-077226

Options or other derivatives

  • Chief Scientific Officer acquired 325,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Hashim Mir Chief Scientific Officer 2025-05-23 Grant or award · Stock Option (Right to Buy) +325,000 325,000 D: show line 1 in the form
Loading xslF345X05/ownership.xml…